TMC Life Sciences Berhad Sustainability Profile
TMC Life Sciences Berhad, a prominent player in the biotechnology and healthcare sector, is headquartered in Malaysia. Founded in 1994, the company has established itself as a leader in providing innovative healthcare solutions, particularly in the fields of regenerative medicine and clinical research. With a strong operational presence across Southeast Asia, TMC Life Sciences focuses on advanced medical technologies and services that enhance patient care. The company offers a range of core products and services, including stem cell therapies and clinical trial management, distinguished by their commitment to quality and scientific excellence. TMC Life Sciences has achieved significant milestones, positioning itself as a trusted name in the industry, recognised for its contributions to medical advancements and patient outcomes.
DitchCarbon Score
How does TMC Life Sciences Berhad's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TMC Life Sciences Berhad's score of 19 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TMC Life Sciences Berhad's reported carbon emissions
In 2023, TMC Life Sciences Berhad reported total carbon emissions of approximately 36,081,000 kg CO2e from Scope 2, 600,410 kg CO2e from Scope 1, and 1,814,000 kg CO2e from Scope 3, specifically related to business travel. This data reflects a comprehensive approach to emissions reporting, with disclosures across all three scopes. The company has shown a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been detailed in the available data. Notably, emissions data is cascaded from its parent company, Thomson Medical Group Limited, indicating a corporate family relationship that influences its sustainability practices. In previous years, TMC Life Sciences reported emissions of approximately 31,190,000 kg CO2e in 2022 and 14,390,000 kg CO2e in 2021 for Scope 2, alongside corresponding Scope 1 emissions of about 316,050 kg CO2e and 263,150 kg CO2e, respectively. This trend highlights the company's ongoing efforts to monitor and manage its environmental impact. While TMC Life Sciences Berhad has not established specific science-based targets or climate pledges, its emissions data and reporting practices align with industry standards, reflecting a growing awareness of climate commitments within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 263,150 | 000,000 | 000,000 |
| Scope 2 | 14,390,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 0,000,000 |
How Carbon Intensive is TMC Life Sciences Berhad's Industry?
How Carbon Intensive is TMC Life Sciences Berhad's Location?
TMC Life Sciences Berhad's Scope 3 Categories Breakdown
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 5% of total emissions under the GHG Protocol, with "Business Travel" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
TMC Life Sciences Berhad's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
TMC Life Sciences Berhad has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Fresenius
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.